Citations (74)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Regina Krattinger, Egle Ramelyte, Joëlle Dornbierer & Reinhard Dummer. (2021) Is single versus combination therapy problematic in the treatment of cutaneous melanoma?. Expert Review of Clinical Pharmacology 14:1, pages 9-23.
Read now
Read now
Amit Verma, Rohit Mathur, Abdullah Farooque, Vandana Kaul, Seema Gupta & Bilikere S Dwarakanath. (2019) T-Regulatory Cells In Tumor Progression And Therapy. Cancer Management and Research 11, pages 10731-10747.
Read now
Read now
Rieneke van de Ven, Traci L. Hilton, Hong-Ming Hu, Christopher J. Dubay, Daniel Haley, Christopher Paustian, Sachin Puri, Walter J. Urba, Brendan D. Curti, Sandra Aung & Bernard A. Fox. (2018) Autophagosome-based strategy to monitor apparent tumor-specific CD8 T cells in patients with prostate cancer. OncoImmunology 7:12.
Read now
Read now
Jonathan Pol, Norma Bloy, Aitziber Buqué, Alexander Eggermont, Isabelle Cremer, Catherine Sautès-Fridman, Jérôme Galon, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial Watch: Peptide-based anticancer vaccines. OncoImmunology 4:4.
Read now
Read now
Klara Soukup & Xinhui Wang. (2015) Radiation meets immunotherapy – a perfect match in the era of combination therapy?. International Journal of Radiation Biology 91:4, pages 299-305.
Read now
Read now
Sandeep Nayar, Prokar Dasgupta & Christine Galustian. (2015) Extending the lifespan and efficacies of immune cells used in adoptive transfer for cancer immunotherapies–A review. OncoImmunology 4:4.
Read now
Read now
Constantin N Baxevanis, Eleftheria A Anastasopoulou, Ioannis F Voutsas, Michael Papamichail & Sonia A Perez. (2015) Immune biomarkers: how well do they serve prognosis in human cancers?. Expert Review of Molecular Diagnostics 15:1, pages 49-59.
Read now
Read now
Jennifer A Westwood, Phillip K Darcy & Michael H Kershaw. (2014) The potential impact of mouse model selection in preclinical evaluation of cancer immunotherapy. OncoImmunology 3:7.
Read now
Read now
Articles from other publishers (66)
Aliva Prity Minz, Debasish Mohapatra, Madhuri Dutta, Manisha Sethi, Deepti Parida, Amlan Priyadarshee Mohapatra, Swayambara Mishra, Salona Kar, Prakash K. Sasmal & Shantibhusan Senapati. (2023) Statins abrogate gemcitabine-induced PD-L1 expression in pancreatic cancer-associated fibroblasts and cancer cells with improved therapeutic outcome. Cancer Immunology, Immunotherapy 72:12, pages 4261-4278.
Crossref
Crossref
Aida Kazemi, Masomeh Goodarzi, Kosar Daneshipour, Hoda Sarabadani, Zahra Shahpar, Bahareh Salmanian Hajiagha, Hadis Kheradjoo & Saman Mohammadzadehsaliani. (2023) Unrevealing the vital role of ncRNAs in Gastric Cancer chemoresistance. Pathology - Research and Practice 250, pages 154761.
Crossref
Crossref
Zhen Gao, Shujie Huang, Sichao Wang, Dezhao Tang, Wei Xu, Ruijie Zeng & Guibin Qiao. (2023) Efficacy and safety of immunochemotherapy, immunotherapy, chemotherapy, and targeted therapy as first-line treatment for advanced and metastatic esophageal cancer: a systematic review and network meta-analysis. The Lancet Regional Health - Western Pacific 38, pages 100841.
Crossref
Crossref
Yu Feng, Yunxia Tao, Haizhu Chen, Yu Zhou, Le Tang, Chenwei Liu, Xingsheng Hu & Yuankai Shi. (2023) Efficacy and safety of immune checkpoint inhibitor rechallenge in non‐small cell lung cancer: A systematic review and meta‐analysis. Thoracic Cancer.
Crossref
Crossref
Maria Davern, Noel E. Donlon, Andrew S. Sheppard, Klaudia D. Majcher, Fiona O’ Connell, Aisling B. Heeran, Malika Grant, Robert A. Farrell, Conall Hayes, Dara Bracken-Clarke, Melissa J. Conroy, Emma Foley, Dermot O’ Toole, Anshul Bhardwaj, Narayanasamy Ravi, John V. Reynolds, Stephen G. Maher, Jacintha O’ Sullivan & Joanne Lysaght. (2022) FLOT and CROSS chemotherapy regimens alter the frequency of CD27+ and CD69+ T cells in oesophagogastric adenocarcinomas: implications for combination with immunotherapy. Journal of Cancer Research and Clinical Oncology 149:7, pages 3753-3774.
Crossref
Crossref
Armineh Rezagholi Lalani, Fatemeh Fakhari, Shakila Radgoudarzi, Nima Rastegar‐Pouyani, Kave Moloudi, Ehsan Khodamoradi, Shahram Taeb & Masoud Najafi. (2023) Immunoregulation by resveratrol; implications for normal tissue protection and tumour suppression. Clinical and Experimental Pharmacology and Physiology 50:5, pages 353-368.
Crossref
Crossref
Daniele Fanale, Alessandra Dimino, Erika Pedone, Chiara Brando, Lidia Rita Corsini, Clarissa Filorizzo, Alessia Fiorino, Maria Chiara Lisanti, Luigi Magrin, Ugo Randazzo, Tancredi Didier Bazan Russo, Antonio Russo & Viviana Bazan. (2022) Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer. Cancers 14:18, pages 4344.
Crossref
Crossref
Julie Lasvergnas, Marie Naigeon, Kader Chouahnia, Laurent Zelek, Nathalie Chaput & Boris Duchemann. (2022) Adoptive cell therapies in thoracic malignancies. Cancer Immunology, Immunotherapy 71:9, pages 2077-2098.
Crossref
Crossref
Marco Carlo Merlano, Nerina Denaro, Danilo Galizia, Fiorella Ruatta, Marcella Occelli, Silvia Minei, Andrea Abbona, Matteo Paccagnella, Michele Ghidini & Ornella Garrone. (2022) How Chemotherapy Affects the Tumor Immune Microenvironment: A Narrative Review. Biomedicines 10:8, pages 1822.
Crossref
Crossref
Ganesh G. DhakadSangita P. ShirsatKaveri P. Tambe. (2022) Review on Immuno-Oncology Agents for Cancer Therapy. Research Journal of Pharmacology and Pharmacodynamics, pages 47-52.
Crossref
Crossref
Ganesh G. DhakadSangita P. ShirsatKaveri P. TambeVinit KairnarRitik. S. Jain. (2022) Review on Immuno-Oncology agents for Cancer Therapy. Asian Journal of Pharmaceutical Research, pages 110-115.
Crossref
Crossref
Simone M. Goldinger, Kristina Buder-Bakhaya, Serigne N. Lo, Andrea Forschner, Meredith McKean, Lisa Zimmer, Chloe Khoo, Reinhard Dummer, Zeynep Eroglu, Elizabeth I. Buchbinder, Paolo A. Ascierto, Ralf Gutzmer, Elisa A. Rozeman, Christoph Hoeller, Douglas B. Johnson, Anja Gesierich, Peter Kölblinger, Naima Bennannoune, Justine V. Cohen, Katharina C. Kähler, Melissa A. Wilson, Jonathan Cebon, Victoria Atkinson, Jessica L. Smith, Olivier Michielin, Georgina V. Long, Jessica C. Hassel, Benjamin Weide, Lauren E. Haydu, Dirk Schadendorf, Grant McArthur, Patrick A. Ott, Christian Blank, Caroline Robert, Ryan Sullivan, Axel Hauschild, Matteo S. Carlino, Claus Garbe, Michael A. Davies & Alexander M. Menzies. (2022) Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis. European Journal of Cancer 162, pages 22-33.
Crossref
Crossref
Kara A Lombardo, Aleksandar Obradovic, Alok Kumar Singh, James L Liu, Gregory Joice, Max Kates, William Bishai, David McConkey, Alcides Chaux, Marie‐Lisa Eich, M Katayoon Rezaei, George J Netto, Charles G Drake, Phuoc Tran, Andres Matoso & Trinity J Bivalacqua. (2021)
BCG
invokes superior
STING
‐mediated innate immune response over radiotherapy in a carcinogen murine model of urothelial cancer
. The Journal of Pathology 256:2, pages 223-234.
Crossref
Crossref
Sophia Stock, Anna-Kristina Kluever, Stefan Endres & Sebastian Kobold. (2022) Enhanced Chimeric Antigen Receptor T Cell Therapy through Co-Application of Synergistic Combination Partners. Biomedicines 10:2, pages 307.
Crossref
Crossref
Hani Babiker, Irene Brana, Daruka Mahadevan, Taofeek Owonikoko, Emiliano Calvo, Danny Rischin, Victor Moreno, Kyriakos P. Papadopoulos, Marka Crittenden, Silvia Formenti, Jordi Giralt, Pilar Garrido, Ainara Soria, Asunción Hervás-Morón, Kosalai Kal Mohan, Matthew Fury, Israel Lowy, Melissa Mathias, Minjie Feng, Jingjin Li & Elizabeth Stankevich. (2021)
Phase I Trial of Cemiplimab, Radiotherapy, Cyclophosphamide, and Granulocyte Macrophage
Colony-Stimulating
Factor in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
. The Oncologist 26:9, pages e1508-e1513.
Crossref
Crossref
Maria Davern, Noel E. Donlon, Robert Power, Conall Hayes, Ross King, Margaret R. Dunne & John V. Reynolds. (2021) The tumour immune microenvironment in oesophageal cancer. British Journal of Cancer 125:4, pages 479-494.
Crossref
Crossref
Hao Nie, Ting Chen, Kefei He, Chanjin Liang, Wei Guo & Xingyuan Shi. (2021) Immunotherapy-Based Therapeutic Strategies for Recurrent Advanced Squamous Cell Carcinoma of the Head and Neck: A Case Report and Literature Review. Frontiers in Immunology 12.
Crossref
Crossref
Xiang Ling, Wenbo Han, Xiaomin Jiang, Xing Chen, Megan Rodriguez, Pingping Zhu, Tong Wu & Wenbin Lin. (2021) Point-source burst of coordination polymer nanoparticles for tri-modality cancer therapy. Biomaterials 270, pages 120690.
Crossref
Crossref
Saber Amin, Michael Baine, Jane Meza, Morshed Alam & Chi Lin. (2020) The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who received definitive surgery of the pancreatic tumor: a retrospective analysis of the National Cancer Database. Radiation Oncology 15:1.
Crossref
Crossref
Xiaohui Wang, Zhiqiang Wu, Wei Qiu, Ping Chen, Xiang Xu & Weidong Han. (2020) Programming CAR T cells to enhance anti-tumor efficacy through remodeling of the immune system. Frontiers of Medicine 14:6, pages 726-745.
Crossref
Crossref
Takuma Takayama, Taro Shimizu, Amr S. Abu Lila, Yuki Kanazawa, Hidenori Ando, Yu Ishima & Tatsuhiro Ishida. (2020) Adjuvant Antitumor Immunity Contributes to the Overall Antitumor Effect of Pegylated Liposomal Doxorubicin (Doxil®) in C26 Tumor-Bearing Immunocompetent Mice. Pharmaceutics 12:10, pages 990.
Crossref
Crossref
Saber Amin, Michael Baine, Jane Meza, Morshed Alam & Chi Lin. (2020) The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who do not receive definitive surgery of the tumor. Clinical and Translational Radiation Oncology 24, pages 34-40.
Crossref
Crossref
Khanidtha Chitphet, Sean M. Geary, Carlos H. F. Chan, Andrean L. Simons, George J. Weiner & Aliasger K. Salem. (2019) Combining Doxorubicin-Loaded PEGylated Poly(Lactide-co-glycolide) Nanoparticles with Checkpoint Inhibition Safely Enhances Therapeutic Efficacy in a Melanoma Model. ACS Biomaterials Science & Engineering 6:5, pages 2659-2667.
Crossref
Crossref
Julia Y. Tsang, Chun-Sing Ho, Yun-Bi Ni, Yan Shao, Ivan K. Poon, Siu-Ki Chan, Sai-Yin Cheung, Ka-Ho Shea, Monalyn Marabi & Gary M. Tse. (2020) Co-expression of HLA-I loci improved prognostication in HER2+ breast cancers. Cancer Immunology, Immunotherapy 69:5, pages 799-811.
Crossref
Crossref
Nien‐Chieh Liao, Yung‐Luen Shih, Ming‐Tak Ho, Tai‐Jung Lu, Ching‐Hsiao Lee, Shu‐Fen Peng, Sy‐Jye Leu & Jing‐Gung Chung. (2019) Cardamonin induces immune responses and enhances survival rate in WEHI‐3 cell–generated mouse leukemia in vivo. Environmental Toxicology 35:4, pages 457-467.
Crossref
Crossref
Mengyuan Liu, Ruoyu Wang, Xuren Sun, Yuting Liu, Zhi Wang, Jin Yan, Xiangyu Kong, Shanshan Liang, Qiuge Liu, Tong Zhao, Xuening Ji, Gang Wang, Fuguang Wang, Guan Wang, Liang Chen, Qingfu Zhang, Weipeng Lv, Heming Li & Mingjun Sun. (2020) Prognostic significance of PD‐L1 expression on cell‐surface vimentin‐positive circulating tumor cells in gastric cancer patients. Molecular Oncology 14:4, pages 865-881.
Crossref
Crossref
Takahiro Wakasaki, Ryuji Yasumatsu, Ryutaro Uchi, Masahiko Taura, Mioko Matsuo, Noritaka Komune & Takashi Nakagawa. (2020) Outcome of chemotherapy following nivolumab treatment for recurrent and/or metastatic head and neck squamous cell carcinoma. Auris Nasus Larynx 47:1, pages 116-122.
Crossref
Crossref
Hui Zhong, Yifan Lai, Rui Zhang, Abdelkader Daoud, Qingyuan Feng, Jia Zhou & Jing Shang. (2020) Low Dose Cyclophosphamide Modulates Tumor Microenvironment by TGF-β Signaling Pathway. International Journal of Molecular Sciences 21:3, pages 957.
Crossref
Crossref
Joana R. Lérias, Eric de Sousa, Georgia Paraschoudi, João Martins, Carolina Condeço, Nuno Figueiredo, Carlos Carvalho, Ernest Dodoo, Andreia Maia, Mireia Castillo-Martin, Antonio Beltrán, Dário Ligeiro, Martin Rao, Alimuddin Zumla & Markus Maeurer. (2020) Trained Immunity for Personalized Cancer Immunotherapy: Current Knowledge and Future Opportunities. Frontiers in Microbiology 10.
Crossref
Crossref
Jared M. Newton, Aurelie Hanoteau, Hsuan-Chen Liu, Angelina Gaspero, Falguni Parikh, Robyn D. Gartrell-Corrado, Thomas D. Hart, Damya Laoui, Jo A. Van Ginderachter, Neeraja Dharmaraj, William C. Spanos, Yvonne Saenger, Simon Young & Andrew G. Sikora. (2019) Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Crossref
Keywan Mortezaee, Wrya Parwaie, Elahe Motevaseli, Hanifeh Mirtavoos-Mahyari, Ahmed Eleojo Musa, Dheyauldeen Shabeeb, Farid Esmaely, Masoud Najafi & Bagher Farhood. (2019) Targets for improving tumor response to radiotherapy. International Immunopharmacology 76, pages 105847.
Crossref
Crossref
Soheila Golchin, Reza Alimohammadi, Mohammad Rostami Nejad & Seyed Amir Jalali. (2019) Synergistic antitumor effect of anti‐PD‐L1 combined with oxaliplatin on a mouse tumor model. Journal of Cellular Physiology 234:11, pages 19866-19874.
Crossref
Crossref
Robert A. Belderbos, Joachim G.J.V. Aerts & Heleen Vroman. (2019) Enhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional Treatment. Molecular Therapy - Oncolytics 13, pages 67-81.
Crossref
Crossref
Bagher Farhood, Keywan Mortezaee, Nasser Hashemi Goradel, Neda Khanlarkhani, Ensieh Salehi, Maryam Shabani Nashtaei, Masoud Najafi & Amirhossein Sahebkar. (2018) Curcumin as an anti‐inflammatory agent: Implications to radiotherapy and chemotherapy. Journal of Cellular Physiology 234:5, pages 5728-5740.
Crossref
Crossref
Yuqing Yang, Agnieszka Swierczak, Mohammad Ibahim, Premila Paiva, Leonie Cann, Andrew W. Stevenson, Jeffrey C. Crosbie, Robin L. Anderson & Peter A.W. Rogers. (2019) Synchrotron microbeam radiotherapy evokes a different early tumor immunomodulatory response to conventional radiotherapy in EMT6.5 mammary tumors. Radiotherapy and Oncology 133, pages 93-99.
Crossref
Crossref
Wenjun Shan, Haiping Zheng, Guofeng Fu, Chenfeng Liu, Zizhen Li, Yuhan Ye, Jie Zhao, Dan Xu, Liping Sun, Xin Wang, Xiao Lei Chen, Shengli Bi, Lei Ren & Guo Fu. (2019) Bioengineered Nanocage from HBc Protein for Combination Cancer Immunotherapy. Nano Letters 19:3, pages 1719-1727.
Crossref
Crossref
Mandy van Gulijk, Floris Dammeijer, Joachim G. J. V. Aerts & Heleen Vroman. (2018) Combination Strategies to Optimize Efficacy of Dendritic Cell-Based Immunotherapy. Frontiers in Immunology 9.
Crossref
Crossref
Nerina Denaro & Marco Carlo Merlano. (2018) Immunotherapy in Head and Neck Squamous Cell Cancer. Clinical and Experimental Otorhinolaryngology 11:4, pages 217-223.
Crossref
Crossref
Maofan Zhang, C. Tilden HaganIVIV, Yuangzeng Min, Hayley Foley, Xi Tian, Feifei Yang, Yu Mi, Kin Man Au, Yusra Medik, Kyle Roche, Kyle Wagner, Zachary Rodgers & Andrew Z. Wang. (2018) Nanoparticle co-delivery of wortmannin and cisplatin synergistically enhances chemoradiotherapy and reverses platinum resistance in ovarian cancer models. Biomaterials 169, pages 1-10.
Crossref
Crossref
Maria C. Ramello, Eric B. Haura & Daniel Abate-Daga. (2018) CAR-T cells and combination therapies: What’s next in the immunotherapy revolution?. Pharmacological Research 129, pages 194-203.
Crossref
Crossref
Lingyu Li, Wei Li, Chang Wang, Xu Yan, Yizhuo Wang, Chao Niu, Xiaoying Zhang, Min Li, Huimin Tian, Cheng Yao, Haofan Jin, Fujun Han, Dongsheng Xu, Wei Han, Dan Li & Jiuwei Cui. (2018) Adoptive transfer of natural killer cells in combination with chemotherapy improves outcomes of patients with locally advanced colon carcinoma. Cytotherapy 20:1, pages 134-148.
Crossref
Crossref
Christin B. DeStefano & Stephen V. Liu. 2018. Early Phase Cancer Immunotherapy. Early Phase Cancer Immunotherapy
199
218
.
María J. de Miguel-Luken, André Mansinho, Valentina Boni & Emiliano Calvo. (2017) Immunotherapy-based combinations: current status and perspectives. Current Opinion in Oncology 29:5, pages 382-394.
Crossref
Crossref
Erika Elgström, Tomas G Ohlsson & Sophie E Eriksson. (2017) Cytokine evaluation in untreated and radioimmunotherapy-treated tumors in an immunocompetent rat model. Tumor Biology 39:4, pages 101042831769755.
Crossref
Crossref
Zhenzhen Wang, Yan Zhang, Zhen Liu, Kai Dong, Chaoqun Liu, Xiang Ran, Fang Pu, Enguo Ju, Jinsong Ren & Xiaogang Qu. (2017) A bifunctional nanomodulator for boosting CpG-mediated cancer immunotherapy. Nanoscale 9:37, pages 14236-14247.
Crossref
Crossref
Juan Du & Baorui Liu. 2017. Personalized Management of Gastric Cancer. Personalized Management of Gastric Cancer
163
175
.
Yizhuo Wang, Chang Wang, Huijie Xiao, Chao Niu, Haitao Wu, Haofan Jin, Cheng Yao, Hua He, Huimin Tian, Fujun Han, Dan Li, Wei Han, Jianting Xu, Jingtao Chen, Jiuwei Cui & Wei Li. (2017) Adjuvant treatment combining cellular immunotherapy with chemotherapy improves the clinical outcome of patients with stage II/III gastric cancer. Cancer Medicine 6:1, pages 45-53.
Crossref
Crossref
Paul R. Kunk, Todd W. Bauer, Craig L. Slingluff & Osama E. Rahma. (2016) From bench to bedside a comprehensive review of pancreatic cancer immunotherapy. Journal for ImmunoTherapy of Cancer 4:1.
Crossref
Crossref
Shaveta Mehta, Tim Illidge & Ananya Choudhury. (2016) Immunotherapy with radiotherapy in urological malignancies. Current Opinion in Urology 26:6, pages 514-522.
Crossref
Crossref
Hee Jin Lee, In Hye Song, In Ah Park, Sun-Hee Heo, Young-Ae Kim, Jin-Hee Ahn & Gyungyub Gong. (2016) Differential expression of major histocompatibility complex class I in subtypes of breast cancer is associated with estrogen receptor and interferon signaling. Oncotarget 7:21, pages 30119-30132.
Crossref
Crossref
Kaichao Feng, Yelei Guo, Hanren Dai, Yao Wang, Xiang Li, Hejin Jia & Weidong Han. (2016) Chimeric antigen receptor-modified T cells for the immunotherapy of patients with EGFR-expressing advanced relapsed/refractory non-small cell lung cancer. Science China Life Sciences 59:5, pages 468-479.
Crossref
Crossref
Henry M. Smilowitz, Peggy L. Micca, Daniel Sasso, Qian Wu, Nathanial Dyment, Crystal Xue & Lynn Kuo. (2015) Increasing radiation dose improves immunotherapy outcome and prolongation of tumor dormancy in a subgroup of mice treated for advanced intracerebral melanoma. Cancer Immunology, Immunotherapy 65:2, pages 127-139.
Crossref
Crossref
Minyu Wang, Rita A Busuttil, Sharon Pattison, Paul J Neeson & Alex Boussioutas. (2016) Immunological battlefield in gastric cancer and role of immunotherapies. World Journal of Gastroenterology 22:28, pages 6373.
Crossref
Crossref
Lauren V. Albrecht, Kathleen J. Green & Adi D. Dubash. 2016. The Cadherin Superfamily. The Cadherin Superfamily
363
397
.
Lysanne Lievense, Joachim Aerts & Joost Hegmans. 2016. Lung Cancer and Personalized Medicine. Lung Cancer and Personalized Medicine
59
90
.
Carlo C. Maley, Konrad Koelble, Rachael Natrajan, Athena Aktipis & Yinyin Yuan. (2015) An ecological measure of immune-cancer colocalization as a prognostic factor for breast cancer. Breast Cancer Research 17:1.
Crossref
Crossref
Chunyan Lan, Andreas Heindl, Xin Huang, Shaoyan Xi, Susana Banerjee, Jihong Liu & Yinyin Yuan. (2015) Quantitative histology analysis of the ovarian tumour microenvironment. Scientific Reports 5:1.
Crossref
Crossref
Vasiliki Gkretsi, Andreas Stylianou, Panagiotis Papageorgis, Christiana Polydorou & Triantafyllos Stylianopoulos. (2015) Remodeling Components of the Tumor Microenvironment to Enhance Cancer Therapy. Frontiers in Oncology 5.
Crossref
Crossref
Gregory K. PennockLaura Q.M. Chow. (2015) The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment. The Oncologist 20:7, pages 812-822.
Crossref
Crossref
Jiuwei Cui, Lingyu Li, Chang Wang, Haofan Jin, Cheng Yao, Yizhuo Wang, Dan Li, Huimin Tian, Chao Niu, Guanjun Wang, Wei Han, Jianting Xu, Jingtao Chen & Wei Li. (2015) Combined cellular immunotherapy and chemotherapy improves clinical outcome in patients with gastric carcinoma. Cytotherapy 17:7, pages 979-988.
Crossref
Crossref
Adam M. Swartz, Kristen A. Batich, Peter E. Fecci & John H. Sampson. (2014) Peptide vaccines for the treatment of glioblastoma. Journal of Neuro-Oncology 123:3, pages 433-440.
Crossref
Crossref
Nicasio Mancini, Lara Marrone, Nicola Clementi, Giuseppe A Sautto, Massimo Clementi & Roberto Burioni. (2015) Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections. Future Microbiology 10:4, pages 665-682.
Crossref
Crossref
Yawen Zheng, Yan Dou, Lili Duan, Changsheng Cong, Aiqin Gao, Qinghua Lai & Yuping Sun. (2015) Using chemo-drugs or irradiation to break immune tolerance and facilitate immunotherapy in solid cancer. Cellular Immunology 294:1, pages 54-59.
Crossref
Crossref
Scott J. Antonia, James Larkin & Paolo A. Ascierto. (2014) Immuno-oncology Combinations: A Review of Clinical Experience and Future Prospects. Clinical Cancer Research 20:24, pages 6258-6268.
Crossref
Crossref
Ezzeldin M. Ibrahim, Meteb E. Al-Foheidi, Mubarak M. Al-Mansour & Ghieth A. Kazkaz. (2014) The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis. Breast Cancer Research and Treatment 148:3, pages 467-476.
Crossref
Crossref
B.B. Su, J.H. Chen, H. Shi, Q.Q. Chen & J. Wan. (2014) Aspirin may modify tumor microenvironment via antiplatelet effect. Medical Hypotheses 83:2, pages 148-150.
Crossref
Crossref